A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-75
SponsorMassachusetts General Hospital
About this trial
We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties of post-LASIK ectasia vs. normal corneas.
Eligibility criteria
Qualifiers
None
Disqualifiers
Have occludable narrow angles (without a patent peripheral iridotomy)
Monocular subjects
Do not or cannot understand the instructions for the imaging
Trial design
Treatments tested in this trial
- Brillouin imaging
Treatment groups
168 Participants
are divided into 7 treatment groups7
Treatment groupsSee each treatment group below.
Locations
1Massachusetts General Hospital02114, BostonMassachusetts, United States
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
Harvard Medical School (HMS and HSDM)
Collaborator
Source ClinicalTrials.gov